APA Alıntı

Serova, M., Tijeras-Raballand, A., Santos, C. D., Albuquerque, M., Paradis, V., Neuzillet, C., . . . de Gramont, A. (2015). Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients. Oncotarget.

Chicago Stili Alıntı

Serova, Maria, et al. "Effects of TGF-beta Signalling Inhibition With Galunisertib (LY2157299) in Hepatocellular Carcinoma Models and in Ex Vivo Whole Tumor Tissue Samples From Patients." Oncotarget 2015.

MLA Alıntı

Serova, Maria, et al. "Effects of TGF-beta Signalling Inhibition With Galunisertib (LY2157299) in Hepatocellular Carcinoma Models and in Ex Vivo Whole Tumor Tissue Samples From Patients." Oncotarget 2015.